1. Home
  2. TOPP vs CVKD Comparison

TOPP vs CVKD Comparison

Compare TOPP & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TOPP
  • CVKD
  • Stock Information
  • Founded
  • TOPP 2014
  • CVKD 2022
  • Country
  • TOPP United States
  • CVKD United States
  • Employees
  • TOPP N/A
  • CVKD N/A
  • Industry
  • TOPP
  • CVKD Medicinal Chemicals and Botanical Products
  • Sector
  • TOPP
  • CVKD Health Care
  • Exchange
  • TOPP NYSE
  • CVKD Nasdaq
  • Market Cap
  • TOPP 26.6M
  • CVKD 29.5M
  • IPO Year
  • TOPP 2025
  • CVKD 2023
  • Fundamental
  • Price
  • TOPP $1.70
  • CVKD $10.28
  • Analyst Decision
  • TOPP
  • CVKD Strong Buy
  • Analyst Count
  • TOPP 0
  • CVKD 1
  • Target Price
  • TOPP N/A
  • CVKD $32.00
  • AVG Volume (30 Days)
  • TOPP 11.8K
  • CVKD 23.0K
  • Earning Date
  • TOPP 08-11-2025
  • CVKD 08-06-2025
  • Dividend Yield
  • TOPP N/A
  • CVKD N/A
  • EPS Growth
  • TOPP N/A
  • CVKD N/A
  • EPS
  • TOPP N/A
  • CVKD N/A
  • Revenue
  • TOPP $16,117,227.00
  • CVKD N/A
  • Revenue This Year
  • TOPP N/A
  • CVKD N/A
  • Revenue Next Year
  • TOPP N/A
  • CVKD N/A
  • P/E Ratio
  • TOPP N/A
  • CVKD N/A
  • Revenue Growth
  • TOPP 0.44
  • CVKD N/A
  • 52 Week Low
  • TOPP $0.97
  • CVKD $5.70
  • 52 Week High
  • TOPP $4.50
  • CVKD $22.90
  • Technical
  • Relative Strength Index (RSI)
  • TOPP N/A
  • CVKD 24.53
  • Support Level
  • TOPP N/A
  • CVKD $10.00
  • Resistance Level
  • TOPP N/A
  • CVKD $13.30
  • Average True Range (ATR)
  • TOPP 0.00
  • CVKD 0.89
  • MACD
  • TOPP 0.00
  • CVKD -0.39
  • Stochastic Oscillator
  • TOPP 0.00
  • CVKD 4.67

About TOPP TOPPOINT HOLDINGS INC

Toppoint Holdings Inc is a truckload services and solutions provider focused on the recycling export supply chain. The company operates in one operating segment where it derives its revenues from the delivery of truckload services.

About CVKD Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.

Share on Social Networks: